Linear IgA-bullous dermatosis: a retrospective clinical case series with a proposed diagnostic algorithm in children and adults
Open Access
- 30 May 2026
- journal article
- Published by Publishing House Zaslavsky in CHILD`S HEALTH
- Vol. 21 (3) , 131-136
Abstract
Background. Linear IgA bullous dermatosis (LABD) is a rare autoimmune subepidermal vesiculobullous disease affecting both children and adults and frequently mimicking infectious or allergic dermatoses. In clinical infectious disease practice, LABD may be misdiagnosed as varicella, recurrent herpes zoster, drug-induced toxicoderma, and other autoimmune bullous dermatoses. The purpose was to provide a pragmatic diagnostic algorithm for differentiating infectious and autoimmune vesiculobullous diseases based on an analysis of own clinical case series and up‑to‑date evidence, with an emphasis on accessible diagnostic steps under limited resources. Materials and methods. This study is a retrospective clinical case series including 5 patients with clinically established LABD (two children aged 3 and 5; three adults aged 19, 25, and 27 years). All participants underwent clinical examination, basic laboratory tests; if indicated, polymerase chain reaction of vesicle contents for varicella zoster virus (VZV) and herpes simplex virus (HSV) 1/2 DNA to exclude the infectious nature of the disease. Based on the analysis of the literature and our own data, modern approaches to clinical morphological and immunopathological verification of LABD (biopsy + direct (DIF)/indirect immunofluorescence, linear IgA) were summarized. The report was prepared in accordance with the CARE 2013 and STROBE guidelines. Results. In 4 of 5 cases, a potential trigger occurred 1–3 months before onset (acute respiratory viral infection or lacunar tonsillitis; nonsteroidal anti-inflammatory drugs/paracetamol use). Fever or systemic toxicity was absent in all patients. Lesions were polymorphic with annular/arciform clusters (“string of pearls”), with moderate pruritus in 4 of 5 cases. Mucosal involvement was not observed, except erosive cheilitis in one child. We propose a stepwise diagnostic algorithm prioritizing exclusion of VZV/HSV infection before prescription of immunosuppressive drugs and emphasizing DIF as the diagnostic gold standard. Conclusions. LABD remains a multidisciplinary diagnostic challenge. In conditions of limited availability of immunopathological verification of the disease, it is advisable to use a structured algorithm: 1) assessment of clinical morphology of rashes and possible triggers; 2) exclusion of herpesvirus infections (VZV/HSV) in bullous rashes; 3) consultation with a dermatologist; 4) referral for biopsy with DIF; 5) assessment of severity; 6) individualized selection of therapy taking into account severity and safety.Keywords
This publication has 18 references indexed in Scilit:
- S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and VenereologyJournal of the European Academy of Dermatology and Venereology, 2024
- Adult‐onset linear IgA bullous dermatosis: a retrospective single‐center cohort study of 81 patients and literature reviewInternational Journal of Dermatology, 2024
- Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case reportClinical Case Reports, 2022
- Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk–Borne Maternal IgAJAMA Dermatology, 2021
- Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa AcquisitaJAMA Dermatology, 2021
- History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA DiseaseJAMA Dermatology, 2021
- Linear IgA bullous dermatosis successfully treated with omalizumab: A case reportJAAD Case Reports, 2019
- A case of recalcitrant linear IgA bullous dermatosis: Successfully treated with rituximabDermatologic Therapy, 2019
- Linear IgA bullous dermatosis treated with rituximabJAAD Case Reports, 2019
- A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescenceBritish Journal of Dermatology, 2016